Related Experiment Videos
Inflammation and atherosclerosis: mechanisms underlying vulnerable plaque
Rob Krams1, Dolf Segers, Babak Mousavi Gourabi
1Thoraxcentre-Room Ee2369, Erasmus MC Rotterdam, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. R.KRAMS@ERASMUS.NL
Journal of Interventional Cardiology
|May 29, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Blood Flow Characteristics in Patients with Asymptomatic Carotid Artery Stenosis Using Ultrasound-based Velocity Vector Imaging.
Ultrasound in medicine & biology·2026
Monitoring in vitro gastric bolus digestion with ultrasound.
Food & function·2026
Sensing of shear stress in vascular endothelial cells - from physiology to pathology.
Journal of cell science·2026
Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022-September 2023.
Emerging infectious diseases·2026
Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease.
Journal of interventional cardiology·2024
Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension.
Journal of interventional cardiology·2024
Examining the Outcomes of Hybrid Coronary Revascularization in Acute STEMI Patients from 2015 to 2022.
Journal of interventional cardiology·2024
Clinical and Laboratory Predictors of Long-Term Outcomes after Catheter Ablation for a Ventricular Electrical Storm.
Journal of interventional cardiology·2024
Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.
Journal of interventional cardiology·2024
Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends.
Journal of interventional cardiology·2023
Comparative assessment of serum adipokine and trace element alterations in papillary thyroid carcinoma.
Journal of Taibah University Medical Sciences·2026
Semaglutide attenuates a proteomics-based dementia risk signature in older adults with overweight or obesity and cardiovascular disease without diabetes: A post hoc analysis of the SELECT phase 3 trial.
Alzheimer's & dementia (Amsterdam, Netherlands)·2026